Organogenesis Holdings Inc (ORGO) earnings · rev $564.2M
These earnings events as JSON? API free 100/dayOrganogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This ORGO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ORGO revenue for 2025-12-31 was $564.2M. Net income was $37.0M. Revenue was up 17.0% from 2024-12-31 to 2025-12-31. ORGO currently screens at market cap $301.1M.
When the next ORGO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 17.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ORGO research stays on the stock page; the tape stays on the quote page.
ORGO earnings FAQ
What are ORGO's latest revenue and net income?
Latest cached Organogenesis Holdings Inc (ORGO) revenue for Dec 31, 2025 was $564.2M. Net income was $37.0M. Statements: https://lician.com/financials/orgo
What is ORGO's latest diluted EPS?
Latest cached Organogenesis Holdings Inc (ORGO) diluted EPS for Dec 31, 2025 was $0.15.
What period does the latest ORGO earnings print cover?
The latest cached Organogenesis Holdings Inc (ORGO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ORGO revenue change from the prior cached period?
Cached Organogenesis Holdings Inc (ORGO) revenue was up 17.0% from $482.0M (Dec 31, 2024) to $564.2M (Dec 31, 2025). Statements: https://lician.com/financials/orgo
Where are ORGO earnings listed?
Cached earnings facts for Organogenesis Holdings Inc (ORGO) are listed at https://lician.com/earnings/orgo. Statements: https://lician.com/financials/orgo
Not investment advice.